Advances in Radiation OncologyCell BiologyPeer-reviewed journal article
Multiscale radiobiological assessment of laser-driven very high energy electrons versus conventional electrons
Camilla GiaccagliaiD, Émilie BayartiD, Maxime DubailiD, Chaitanya VarmaiD, Sophie HeinrichiD, J. GautieriD, Amar Tafzi, Olena KononenkoiD, J.-P. Goddet, Jeevan Babu Amakkattu, Isabelle Lamarre, Charles FouilladeiD, A. FlaccoiD
Abstract
PurposeThis study systematically investigates the radiobiological effects of Very High Energy Electrons (VHEE) generated by a laser-plasma accelerator (LPA), in comparison with Conventional Intermediate Energy Electrons (CIEE) from a conventional linear accelerator (LINAC). Using in vitro, ex vivo, and in vivo models, we evaluate and compare their potential toxicity on healthy tissues. Methods and MaterialsCell survival, tissue response, and developmental toxicity were assessed across three biological models. In vitro, human fibroblasts (MRC5-hTERT) were used to generate post-irradiation survival curves. Ex vivo, precision-cut lung slices (PCLS) from mice were analyzed for radiation-induced inhibition of cell proliferation. In vivo, zebrafish embryos were used to evaluate developmental toxicity through body length and spinal curvature measurements. VHEE irradiations were performed using a broadband electron beam spanning 50-300 MeV, using the Salle Jaune LPA (Laboratoire dOptique Appliquee, France), while CIEE exposures were performed with a 7 MeV conventional LINAC (Institut Curie, France). ResultsIn vitro, MRC5-hTERT cells showed no significant difference in radiosensitivity between VHEE and CIEE, with comparable D10 values (p-value = 0.7). In the ex vivo model, both beams induced a dose-dependent decrease in cell division with no significant inter-beam differences at any dose level (p-value > 0.99). In vivo, zebrafish embryos exhibited dose-dependent body shortening and increased spinal curvature following both VHEE and CIEE exposure. No significant differences were observed between the two modalities at matched doses for any measured metric (p-value[≥] 0.5). ConclusionThis study presents the first comprehensive radiobiological evaluation of a laser-driven VHEE beam across multiple biological models. Under the investigated conditions, VHEE and CIEE irradiations exhibit similar biological toxicity. These findings support the feasibility and potential of VHEE generated with LPA for future clinical applications.
- organism: human
- organism: mouse
- organism: zebrafish
- research focus: host-pathogen & immune response
- research focus: development & morphogenesis
- approach: experimental assay
- Citations
- 2
- FWCI
- 4.78
- Field percentile
- top 8%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Laser-driven VHEE pulsed fast fractionation (PFF): second-scale inter-pulse timing can modulate normal tissue toxicity in vivo
Camilla Giaccaglia, Émilie Bayart, … A. Flacco·bioRxiv·Sep 12, 2026
- Modification of the microstructure of the CERN- CLEAR-VHEE beam at the picosecond scale modifies ZFE morphogenesis but has no impact on hydrogen peroxide production.
Houda Kacem, L. L. Kunz, … Marie‐Catherine Vozenin·Radiotherapy and OncologyPeer-reviewed·May 20, 2025
- Increased Relative Biological Effectiveness of Orthovoltage X-rays Compared to γ-rays in Preclinical Irradiation
B. I. Bell, J. Vercellino, … C. Guha·bioRxiv·Feb 18, 2022
- Investigating Rat-Brain Normal Tissue and Tumor FLASH Effects with a Novel Very High Energy Electron Beam
Tyler V. Kay, Anna L. Price, … Mark Oldham·bioRxiv·Sep 5, 2025
- An empirical model to predict survival curve and relative biological effectiveness after helium and carbon ion irradiation based solely on the cell survival after photon irradiation
D. B. Flint, S. J. Bright, … G. O. Sawakuchi·bioRxiv·Jun 19, 2020
- Ultra-High Dose Rate Helium Ion Beams: Minimizing Brain Tissue Damage while Preserving Tumor Control
Ivana Đokić, Mahmoud Moustafa, … Amir Abdollahi·Molecular Cancer TherapeuticsPeer-reviewed·Dec 31, 2024